<DOC>
	<DOCNO>NCT00095069</DOCNO>
	<brief_summary>The purpose trial study safety effectiveness MK0928 adult insomnia .</brief_summary>
	<brief_title>Efficacy Safety MK0928 Insomnia Adults ( 0928-003 ) ( COMPLETED )</brief_title>
	<detailed_description />
	<mesh_term>Sleep Initiation Maintenance Disorders</mesh_term>
	<mesh_term>Gaboxadol</mesh_term>
	<criteria>Diagnosis insomnia</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>64 Years</maximum_age>
	<verification_date>January 2015</verification_date>
</DOC>